Oculis Holding AG (OCS) Current Leases (2021 - 2026)
Oculis Holding AG (OCS) recorded quarterly Current Leases of $531233.9 in Q1 2026, down 15.42% quarter-over-quarter from $628087.2 in Q4 2025, and up 57.11% on a YoY basis from $338124.2 in Q1 2025.
Oculis Holding AG (OCS) Current Leases (2021 - 2026) Analysis & Trends
Oculis Holding AG's Current Leases history runs 6 years deep, the most recent figure standing at $531233.9 for Q1 2026.
- In Q1 2026, Current Leases rose 57.11% year-over-year to $531233.9; the TTM figure through Mar 2026 stood at $531233.9 (up 57.11% YoY), while the FY2025 annual figure was $628087.2, up 74.67% from the prior year.
- Current Leases was $531233.9 for Q1 2026 at Oculis Holding AG, down from $628087.2 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $628087.2 in Q4 2025 to a low of $147399.1 in Q4 2022.
- Historically, Current Leases has averaged $341289.4 across 5 years, with a median of $359579.4 in 2024.
- The sharpest annual moves came in 2022 and 2024: Current Leases dropped 29.58% in 2022, then jumped 83.69% in 2024.
- A 5-year view of Current Leases shows it stood at $147399.1 in 2022, then surged by 33.08% to $196159.7 in 2023, then soared by 83.31% to $359579.4 in 2024, then surged by 74.67% to $628087.2 in 2025, then decreased by 15.42% to $531233.9 in 2026.
- The last three Current Leases figures came in at $531233.9 (Q1 2026), $628087.2 (Q4 2025), and $526296.1 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Oculis Holding AG | 8.23 Bn | 7.92 Bn | - | 531,233.95 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 531,233.95 |
| Dec 31, 2025 | 628,087.24 |
| Sep 30, 2025 | 526,296.11 |
| Jun 30, 2025 | 374,445.97 |
| Mar 31, 2025 | 338,124.16 |
| Dec 31, 2024 | 359,579.38 |
| Sep 30, 2024 | 362,421.07 |
| Jun 30, 2024 | 361,594.47 |
| Mar 31, 2024 | 208,514.18 |
| Dec 31, 2023 | 196,159.68 |
| Sep 30, 2023 | 206,051.77 |
| Jun 30, 2023 | 196,855.07 |
| Dec 31, 2022 | 147,399.11 |
| Dec 31, 2021 | 209,308.90 |